CLIO INC has a total of 34 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2011. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals and biotechnology are RODOS BIOTARGET GMBH, MINOVIA THERAPEUTICS LTD and CAR T SHANGHAI BIOTECHNOLOGY CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | China | 4 | |
#4 | Japan | 4 | |
#5 | EPO (European Patent Office) | 3 | |
#6 | Australia | 2 | |
#7 | Singapore | 2 | |
#8 | Canada | 1 | |
#9 | India | 1 | |
#10 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Dezawa Mari | 30 |
#2 | Yoshida Masanori | 30 |
#3 | Fujiyoshi Yoshinori | 11 |
#4 | Minatoguchi Shinya | 10 |
#5 | Yoshida Masayori | 4 |
#6 | Idesawa Mari | 4 |
#7 | Tominaga Teiji | 3 |
#8 | Kuroda Yasumasa | 2 |
#9 | Aiba Setsuya | 1 |
#10 | Yamasaki Kenshi | 1 |
Publication | Filing date | Title |
---|---|---|
WO2014163206A1 | Use of functional melanocytes readily differentiated from multilineage-differentiating stress-enduring (Muse) cells, distinct stem cells in human fibroblasts | |
CN105188754A | Pharmaceutical composition including migratory factor for guiding pluripotent stem cells to injury | |
JP2015160820A | Pluripotent stem cell for treating chronic renal damage | |
JP2015159895A | Pluripotent stem cell for cerebral infarction treatment | |
WO2014027474A1 | Pluripotent stem cell that induces repair and regeneration after myocardial infarction | |
JP2014132830A | Pluripotent stem cell that can be isolated from umbilical cord or adipose tissue of living body | |
JP2014133703A | Composition for cell therapy for allotransplant including ssea-3 positive pluripotent stem cell that can be isolated from biological tissue |